Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
20th Jan 202310:39 amRNSTransaction in Own Shares
18th Jan 20235:22 pmRNSTransaction in Own Shares
16th Jan 20237:00 amRNSInterim Dividend Declaration and Share Buy-Back
9th Jan 202312:00 pmRNSInvestee Company Updates
6th Jan 20234:43 pmRNSHolding(s) in Company
22nd Dec 20222:57 pmRNSDirector/PDMR Shareholding
29th Nov 20224:15 pmRNSDirector/PDMR Shareholding
18th Nov 202210:32 amRNSDirector/PDMR Shareholding
2nd Nov 202212:30 pmRNSInvestee Company - Update Denison and Partners
19th Oct 202212:11 pmRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSInterim Results
6th Oct 202210:02 amRNSNotice of Interim Results & Investor Presentation
20th Sep 202211:25 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSTrading Update
15th Aug 20224:39 pmRNSDirector/PDMR Shareholding
25th Jul 20223:31 pmRNSResult of AGM
15th Jul 20221:52 pmRNSDirector/PDMR Shareholding
1st Jul 20223:04 pmRNSNotice of AGM
21st Jun 202210:14 amRNSInvestor Presentation - change of date
13th Jun 20224:53 pmRNSEx-Dividend Date
13th Jun 20227:00 amRNSFinal Results
3rd May 20224:08 pmRNSInvestee Company LEBC Holdings
21st Apr 202212:29 pmRNSDirector/PDMR Shareholding
8th Apr 20229:43 amRNSAward of Shares under Share Incentive Plan
4th Apr 20224:09 pmRNSTransfer of Treasury Shares
24th Mar 20227:00 amRNSNew Investment - Denison and Partners Limited
2nd Mar 20224:51 pmRNSDirector/PDMR Shareholding
1st Mar 20221:30 pmRNSCompletion of Disposal
17th Feb 20222:55 pmRNSDirector/PDMR Shareholding
8th Feb 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSInvestee Company Disposal – Summa Insurance
10th Jan 20227:10 amRNSInvestee Company Update: LEBC Holdings Limited
22nd Dec 20217:00 amRNSInvestee Company Disposal - Walsingham Motor
13th Dec 202111:00 amRNSChange of Registrar
29th Nov 20215:46 pmRNSDirector/PDMR Shareholding
9th Nov 20213:30 pmRNSInvestee Company Update - Nexus Underwriting
9th Nov 202112:00 pmRNSDirector/PDMR Shareholding
25th Oct 20213:48 pmRNSDirector/PDMR Shareholding
19th Oct 20217:01 amRNSInvestee Company Update – CBC UK Limited
19th Oct 20217:00 amRNSInterim Results
8th Oct 20217:00 amRNSInvestee Company Update - Nexus Underwriting
7th Oct 20213:15 pmRNSInvestee Company Update - XPT Group LLC
10th Sep 20214:18 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSTrading Statement
3rd Sep 20219:56 amRNSDirector/PDMR Shareholding
1st Sep 20218:30 amRNSReplacement: Investee Company Disposal
1st Sep 20217:00 amRNSInvestee Company Update - MB Prestige Holdings
10th Aug 20217:00 amRNSInvestee Company Update
5th Aug 202110:12 amRNSDirector/PDMR Shareholding
14th Jul 20215:44 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.